全球纳米毒性和安全市场

全球纳米毒性和安全市场分析为 6240 万美元，预计到 2027 年将达到 1.516 亿美元，从 2022 年到 2027 年的复合年增长率为 16.61%。

按技术来看，扫描电子显微镜细分市场将在 2021 年占据最大的市场份额，收入为 4368 万美元。

按工艺来看，2021 年物理化学工艺细分市场的市场份额略高于形态工艺。

通过毒性测试，细胞培养（体外）部分在 2021 年占据了市场份额。

就纳米粒子而言，2021 年的大部分市场份额将来自二氧化钛纳米粒子领域。各种类型的基于氧化钛的纳米颗粒可以通过四种不同的晶体结构进行区分：金红石、锐钛矿、板钛矿和二氧化钛，其中金红石和锐钛矿是消费品中最常用的。

就毒性而言，纳米毒性和安全市场在 2021 年看到剂量依赖性毒性部分产生的收入最多。

从应用来看，医药板块在预测期内将保持优势，并将通过纳米技术在药物输送、癌症和动脉硬化等疾病的成像和诊断以及听力和视力障碍等方面的应用，继续实现稳定增长。已被分析成长为

按地区划分，北美地区将在 2021 年占据压倒性的市场份额。由于生命科学、农业、工业能源和其他领域的各种研发活动对纳米毒性测试设备的需求不断增长，以及该地区主要参与者的强大存在，美国是该市场的最大收入贡献者。

内容

第 1 章纳米毒性和安全市场：概述

第 2 章纳米毒性和安全市场：执行摘要

第 3 章纳米毒性和安全市场：景观

• 市场份额分析：主要参与者
• 产品比较：主要公司
• 财务分析：前 5 名公司
• 专利分析：主要公司
• 价格分析

第四章纳米毒性与安全市场的影响因素

• 市场驱动力
• 市场製约因素
• 市场机会
• 波特五力分析
  • 供应商的议价能力
  • 客户议价能力
  • 新进入者的威胁
  • 现有公司之间的竞争关係
  • 替代产品的威胁

第 5 章纳米毒性和安全市场：战略分析

• 价值链分析
• 市场机会分析
• 市场生命週期
• 供应商/分销商分析

第 6 章纳米毒性和安全市场：按技术分类（市场规模（十亿美元））

• 扫描电子显微镜 (SEM)
• 透射电子显微镜
• 其他（X 射线衍射、热分析）

第 7 章纳米毒性和安全性市场：按生物系统（市场规模（单位：十亿美元））

• 单元格
• 组织
• 生物

第 8 章纳米毒性和安全市场：按工艺（市场规模（十亿美元））

• 形态过程
• 物理化学过程

第 9 章纳米毒性和安全市场：通过毒性测试（市场规模（十亿美元））

• 细胞培养（体外）
  • 二维模型
  • 3D 模型
• 有机体（体内）
  • 水生生物模型
  • 小型囓齿动物（哺乳动物模型）

第 10 章纳米毒性和安全性市场：按纳米粒子（市场规模（十亿美元））

• 二氧化钛纳米粒子
• 银纳米粒子
• 其他

第 11 章纳米毒性和安全市场：按毒性（市场规模（单位：十亿美元））

• 尺寸依赖性毒性
• 表面依赖性毒性
• 形状依赖性毒性
• 聚集/聚集依赖性毒性
• 剂量依赖性毒性

第 12 章纳米毒性和安全性市场：按应用（市场规模（十亿美元））

• 能源
• 材料/健康
• 医疗系统
• 农业
• 药品
• 化妆品
• 其他（工程/食品/其他）

第 13 章纳米毒性和安全市场：按地区（市场规模（十亿美元））

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 哥伦比亚
  • 其他南美国家
• 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚和新西兰
  • 其他亚太国家

第 14 章纳米毒性和安全市场：熵

• 推出新产品
• 併购 (M&A)、业务合作/合伙、合资

第 15 章纳米毒性和安全市场：公司分析

• 市场份额、公司收益、产品、併购 (M&A)、趋势
• 分析公司（共 10 家公司）

Nano Toxicity and Safety refers to the potential adverse health effects related to engineered nanomaterial exposure and different techniques, tools, and approaches related to the safety of nanotechnology. The nanoparticles' potential for danger is evident due to the high surface area to volume ratio, which can make them highly reactive or catalytic. In addition, they can pass through cell membranes in organisms and may interact with biological systems. The global Nano Toxicity and Safety Market is analyzed to be $62.4 million and is projected to reach $151.6 million in 2027, growing with a CAGR of 16.61 % during 2022-2027. The Nano Toxicity and Safety market is segmented by technique, by process, by toxicity test, by nano particles, by toxicity, and by application in this report. The market is also segmented by geography, which include North America, South America, Europe, and Asia-Pacific.

Nano Toxicity and Safety Market Segment Analysis - By Technique

Nano Toxicity and Safety Market is segmented by technique such as Scanning Electron Microscopy, Transmission Electron Microscopy, and Others (X-ray Diffraction, Thermal Analysis). In 2021, the Scanning Electron Microscopy segment held the greatest market share, generating $43.68 million. Depending on the size and substance used to create nanomaterialss, scanning electron microscopy and transmission electron microscopy are two microscopic methods that characterize morphology. Studies using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) have been carried out to learn more about the morphology, structure, and size of IO-NPs.

Nano Toxicity and Safety Market Segment Analysis - By Process

In terms of process, the Physicochemical Process segment achieved slightly bigger market share of the Nano Toxicity and Safety Market in 2021 than Morphological Process. Nanotoxicology is based on a variety of factors, including size, surface area, morphology, composition, surface chemistry, aggregation/agglomeration phenomena, etc. The interaction of Nanomaterials with biological cells is greatly impacted by their morphological and physicochemical characteristics, which may also affect their toxicity.

Nano Toxicity and Safety Market Segment Analysis - By Toxicity Test

In terms of toxicity test, the Cell Cultures (In Vitro) segment dominated the market share in 2021. The Cell Cultures (In Vitro) segment can be subcategorized into 2D models and 3D models. The most popular technique for determining NM toxicity on a 2D platform involves exposing adherent cells to an NM dispersion where the NMs are dispersed in the media.

Nano Toxicity and Safety Market Segment Analysis - By Nanoparticle

By nanoparticle, the majority of market share in 2021 was from the Titanium Dioxide Nanoparticles segment. Materials use titanium dioxide (TiO2) in a variety of ways such as paper, plastic, ceramics, rubber, printer ink, floor coverings, catalysts, fabrics and textiles, cosmetics, food colors, medicines, paints, coatings, and electronic components. Four different crystalline structures-rutile, anatase, brookite, or titanium dioxide-can be used to distinguish the various types of TiO2-based NMs, with rutile and anatase being the most frequently used in consumer goods.

Nano Toxicity and Safety Market Segment Analysis - By Toxicity

By toxicity, Nano Toxicity and Safety Market is segmented into Size-dependent Toxicity, Surface-dependent Toxicity, Shape-dependent Toxicity, Aggregation or agglomeration-dependent Toxicity and Dose-dependent Toxicity. As one of the critical factors affecting toxicity, the Dose-dependent Toxicity segment generated the most revenue in 2021 Nano Toxicity and Safety market. To determine the minimum dose of NPs which is induces toxicity, dose is very important.

Nano Toxicity and Safety Market Segment Analysis - By Application

Nano Toxicity and Safety Market is segmented by its various application such as Energy, Materials and Health, Medical Systems, Agriculture, Pharmaceutical, Cosmetic, and Others (Engineering, Food and Others). The Pharmaceutical segment is analyzed to hold the dominance and to grow steadily during the forecast period owing to the utilization of nanotechnology in drug delivery, imaging & diagnosis of diseases such as cancer and atherosclerosis, as well as hearing & vision disorders. Thus, the importance of nanomaterial toxicity testing is more highlighted.

Nano Toxicity and Safety Market Segment Analysis - By Geography/Country

The report comprises of the region wise study of the global market including North America, South America, Europe, and Asia-Pacific. Among them, North America region accounted for the dominant market share in 2021. The United States contributes to the most revenue to the market with growing need for nano-toxicity testing devices for various research and development activities in the sectors of Life Science, Agriculture, Industrial Energy, and others as well as the strong presence of key players in this region.

Nano Toxicity and Safety Market- Drivers

One of the primary factors driving the growth in global Nano Toxicity and Safety market is emerging technological advancements in nanotechnology and nanotech devices. Some of advanced nanotechnologies are nano-identification, nano-impact, nano-scratch, and nano-tribological, and they are now used in many testing procedures to better understand materials at the nanoscale. Based on the advanced nanotechnologies, increase in adoption of Nano-toxicology testing in various end-use industries such as the energy, healthcare, cosmetic industry, and others is set to propel the market growth.

Nano Toxicity and Safety - Competitive Landscape

Major companies in the global Nano Toxicity and Safety Market profiled in this report include Horiba, CytoViva, Schaefer-Tec AG, Thermo Fisher Scientific, Carl Zeiss NTS Ltd., Hitachi High-Technologies Corporation, SGS SA, Eurofins Scientific, Charles River Laboratories International Inc., Enviroscience Inc. Technology launches, acquisitions, partnerships and R&D activities are key strategies adopted by the key players in the Nano Toxicity and Safety market.

Nano Toxicity and Safety - Recent Developments

In May 2022, HORIBA UK announces that it has joined the lifETIME Centre for Doctoral Training (CDT) as an Industry Partner. This partnership aims to provide a new generation of scientists with skills and approaches to reduce and replace the need for animal testing, so transforming drug discovery, toxicology screening and regenerative medicine.

In August 2021, Eurofins Discovery, a leading provider of products and services to the drug discovery industry and a Eurofins Scientific company, announced a new commercial collaboration with Fusion Antibodies plc, a specialist in the pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications.

In November 2020, Carl Zeiss NTS Ltd presented a new generation of its field emission scanning electron microscope (FESEM) family ZEISS GeminiSEM. The new models ZEISS GeminiSEM 360, 460 and 560 are tailored for sub-nanometer imaging and effortless analytics. Users benefit from innovations in the electron optics and a new chamber design offering better image quality, usability and flexibility. ZEISS GeminiSEM 560 now being introduced brings the ZEISS Gemini 3 column to the market for the first time.

Nano Toxicity and Safety - Report Scope and Coverage

The base year of the study is 2021, with forecast done up to 2027. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Nano Toxicity and Safety market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, and Nano Toxicity and Safety manufacturing method analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the key global Nano Toxicity and Safety Market players, to define, describe and analyze the sales value, market share, SWOT analysis and development plans in upcoming years.

By Technique: Scanning Electron Microscopy, Transmission Electron Microscopy, Others (X-ray Diffraction, Thermal Analysis)

By Process: Morphological Process, Physicochemical Process

By Toxicity Tests: Cell Cultures (In Vitro) (2D Models & 3D Models), Living Organisms (In Vivo) (Aquatic Models, Small Rodents)

By Nanoparticles: Titanium Dioxide Nanoparticles, Silver Nanoparticles, Others

By Toxicity: Size-dependent Toxicity, Surface-dependent Toxicity, Shape-dependent Toxicity, Aggregation or agglomeration-dependent Toxicity, Dose-dependent Toxicity

By Application: Energy, Materials and Health, Medical Systems, Agriculture, Pharmaceutical, Cosmetic, Others (Engineering, Food and Others)

By Region: North America, South America, Europe, Asia-Pacific

Table of Contents

1. Nano Toxicity and Safety Market- Market Overview

• 1.1 Definitions and Scope

2. Nano Toxicity and Safety Market- Executive Summary

• 2.1 Market Revenue, Market Size and Key Trends by Company

3. Nano Toxicity and Safety Market- Landscape

• 3.1 Market Share Analysis- Top Companies
• 3.2 Product Benchmarking- Top Companies
• 3.3 Top 5 Financials Analysis
• 3.4 Patent Analysis- Top Companies
• 3.5 Pricing Analysis

4. Nano Toxicity and Safety Market- Market Forces

• 4.1 Market Drivers
• 4.2 Market Constraints
• 4.3 Market Opportunities
• 4.4 Porters five force model
  • 4.4.1 Bargaining power of suppliers
  • 4.4.2 Bargaining powers of customers
  • 4.4.3 Threat of new entrants
  • 4.4.4 Rivalry among existing players
  • 4.4.5 Threat of substitutes

5. Nano Toxicity and Safety Market -Strategic analysis

• 5.1 Value chain analysis
• 5.2 Opportunities analysis
• 5.3 Market life cycle
• 5.4 Suppliers and distributors Analysis

6. Nano Toxicity and Safety Market- By Technique (Market Size -$Billion)

• 6.1 Scanning Electron Microscopy
• 6.2 Transmission Electron Microscopy
• 6.3 Others (X-ray Diffraction, Thermal Analysis)

7. Nano Toxicity and Safety Market- By Biological Systems (Market Size -$Billion)

• 7.1 Cells
• 7.2 Tissues
• 7.3 Living Organisms

8. Nano Toxicity and Safety Market- By Process (Market Size -$Billion)

• 8.1 Morphological Process
• 8.2 Physicochemical Process

9. Nano Toxicity and Safety Market- By Toxicity Tests (Market Size -$Billion)

• 9.1 Cell Cultures (In Vitro)
  • 9.1.1 2D Models
  • 9.1.2 3D Models
• 9.2 Living Organisms (In Vivo)
  • 9.2.1 Aquatic Models
  • 9.2.2 Small Rodents (Mammal models)

10. Nano Toxicity and Safety Market- By Nanoparticles (Market Size -$Billion)

• 10.1 Titanium Dioxide Nanoparticles
• 10.2 Silver Nanoparticles
• 10.3 Others

11. Nano Toxicity and Safety Market- By Toxicity (Market Size -$Billion)

• 11.1 Size-dependent Toxicity
• 11.2 Surface-dependent Toxicity
• 11.3 Shape-dependent Toxicity
• 11.4 Aggregation or agglomeration-dependent Toxicity
• 11.5 Dose-dependent Toxicity

12. Nano Toxicity and Safety Market- By Application (Market Size -$Billion)

• 12.1 Energy
• 12.2 Materials and Health
• 12.3 Medical Systems
• 12.4 Agriculture
• 12.5 Pharmaceutic
• 12.6 Cosmetic
• 12.7 Others (Engineering, Food and Others)

13. Nano Toxicity and Safety Market - By Geography (Market Size -$Billion)

• 13.1 North America
  • 13.1.1 U.S.
  • 13.1.2 Canada
  • 13.1.3 Mexico
• 13.2 South America
  • 13.2.1 Brazil
  • 13.2.2 Argentina
  • 13.2.3 Colombia
  • 13.2.4 Rest of South America
• 13.3 Europe
  • 13.3.1 U.K
  • 13.3.2 Germany
  • 13.3.3 Italy
  • 13.3.4 France
  • 13.3.5 Spain
  • 13.3.6 Rest of Europe
• 13.4 Asia Pacific
  • 13.4.1 China
  • 13.4.2 India
  • 13.4.3 Japan
  • 13.4.4 South Korea
  • 13.4.5 Australia & New Zealand
  • 13.4.6 Rest of Asia Pacific

14. Nano Toxicity and Safety Market- Entropy

• 14.1 New Product Launches
• 14.2 M&A's, Collaborations, JVs and Partnerships

15. Nano Toxicity and Safety Market Company Analysis

(Market Share, Company Revenue, Products, M&A, Developments)

• 15.1 Company 1
• 15.2 Company 2
• 15.3 Company 3
• 15.4 Company 4
• 15.5 Company 5
• 15.6 Company 6
• 15.7 Company 7
• 15.8 Company 8
• 15.9 Company 9
• 15.10 Company 10

"*Financials would be provided on a best-efforts basis for private companies"